[1]

[2]

[3]

HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.

[4]

[5]

[6]

[7]

[8]

CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.

[9]

. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.

[10]

. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.

[11]

. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.

[12]

[13]

[14]

[15]

LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.

组别	例数	Hb(g/L)	RBC(×10¹²/L)	HCT	PLT(×10⁹/L)
不良反应组
输血前	10	49±13	2.57±0.56	0.25±0.06	47±5
输血后	10	81±8	3.72±0.65	0.33±0.06	102±13
无不良反应组
输血前	146	52±15	2.62±0.58	0.27±0.07	49±6
输血后	146	87±9	4.20±0.68	0.37±0.07	132±18

组别	例数	Hb(g/L)	RBC(×10¹²/L)	HCT	PLT(×10⁹/L)
不良反应组
输血前	10	49±13	2.57±0.56	0.25±0.06	47±5
输血后	10	81±8	3.72±0.65	0.33±0.06	102±13
无不良反应组
输血前	146	52±15	2.62±0.58	0.27±0.07	49±6
输血后	146	87±9	4.20±0.68	0.37±0.07	132±18

组别	例数	PT(s)	APTT(s)	TT(s)	FiB(g/L)
不良反应组
输血前	10	16.5±2.37	36.5±4.1	20.1±3.0	1.1±0.1
输血后	10	20.5±2.7^#	42.5±4.4^#	30.1±1.7^#	2.1±0.5^#
无不良反应组
输血前	146	16.3±2.25	36.4±4.0	20.8±3.1	1.1±0.1
输血后	146	13.3±2.7^*	28.4±3.7^*	17.3±1.4^*	4.0±0.7^*

组别	例数	PT(s)	APTT(s)	TT(s)	FiB(g/L)
不良反应组
输血前	10	16.5±2.37	36.5±4.1	20.1±3.0	1.1±0.1
输血后	10	20.5±2.7^#	42.5±4.4^#	30.1±1.7^#	2.1±0.5^#
无不良反应组
输血前	146	16.3±2.25	36.4±4.0	20.8±3.1	1.1±0.1
输血后	146	13.3±2.7^*	28.4±3.7^*	17.3±1.4^*	4.0±0.7^*

RichHTML

PDF (PC)

[1]	郭兑山, 王德智. 异位妊娠与自身输血[J]. 中国实用妇科与产科杂志, 2000,16(4):210-211.
[2]	赵绥民, 田兆嵩. 急性失血病人的成分输血[J]. 中国输血杂志, 1999,12(1):46-47.
[3]	何静, 熊鸿燕. 创伤输血的研究进展[J]. 中华创伤杂志, 2006,22(4):316-318.
[4]	SPINELLA PC.Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications[J].Crit Care Med, 2008,36(7 Suppl):S340-S345.
[5]	MYNSTER T, CHRISTENSEN IJ, MOESGAARD F, et al.Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group[J]. Br J Surg, 2000,87(11):1553-1562.